| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a776308e51e2266a6e44c2e243c70233 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D315-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-20 |
| filingDate |
1998-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cacc6c14cf2e367644aadeafb0e4fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_345c524c0b00b681c73302746ec6b4a3 |
| publicationDate |
2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1323715-A1 |
| titleOfInvention |
Inhibitors of cholesterol esterase |
| abstract |
The present invention provides novel haloenol lactones that are effective asnactive site inhibitors of cholesterol esterase. By inhibiting cholesterol esterase theninhibitors of the present invention provide a new approach to the treatment ofnhypercholesterolemia through limiting the bioavailability of dietary cholesterol. |
| priorityDate |
1997-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |